Cargando…

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study

INTRODUCTION: Stereotactic MR-guided adaptive radiotherapy (SMART) is an attractive modality of radiotherapy for pancreatic tumors. The objectives of this prospective registry study were to report the dosimetric benefits of daily adaptation of SMART and the first clinical results in pancreatic tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalet, Morgan, Bordeau, Karl, Cantaloube, Marie, Valdenaire, Simon, Debuire, Pierre, Simeon, Sebastien, Portales, Fabienne, Draghici, Roxana, Ychou, Marc, Assenat, Eric, Dupuy, Marie, Gourgou, Sophie, Colombo, Pierre-Emmanuel, Carrere, Sebastien, Souche, François-Regis, Aillères, Norbert, Fenoglietto, Pascal, Azria, David, Riou, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959839/ https://www.ncbi.nlm.nih.gov/pubmed/35356227 http://dx.doi.org/10.3389/fonc.2022.842402

Ejemplares similares

Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2022)

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2023)

Magnetic Resonance–Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2021)

Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2022)

Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma
por: Cantaloube, Marie, et al.
Publicado: (2021)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022)

Implementation of the Calypso system: a commissioning experience
por: Prunaretty, Jessica, et al.
Publicado: (2023)

Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management
por: Quesada, Stanislas, et al.
Publicado: (2022)

Comparison of volumetric‐modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery
por: Molinier, Jessica, et al.
Publicado: (2016)

Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the montpellier comprehensive cancer center
por: Fenoglietto, Pascal, et al.
Publicado: (2011)

IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center
por: Vieillot, Sabine, et al.
Publicado: (2012)

Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer
por: Vieillot, Sabine, et al.
Publicado: (2010)

Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
por: Serre, Antoine, et al.
Publicado: (2007)

Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies
por: Vieillot, Sabine, et al.
Publicado: (2011)

Simultaneous integrated boost plan comparison of volumetric‐modulated arc therapy and sliding window intensity‐modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer
por: Riou, Olivier, et al.
Publicado: (2013)

Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients
por: Riou, Olivier, et al.
Publicado: (2015)

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans
por: Menkarios, Cathy, et al.
Publicado: (2007)

Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial
por: Lemanski, Claire, et al.
Publicado: (2013)

Survival after Multimodal Treatment Including Surgery for Metastatic Esophageal Cancer: A Systematic Review
por: Bardol, Thomas, et al.
Publicado: (2022)

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
por: Prunaretty, Jessica, et al.
Publicado: (2023)

Three Years of Salvage IMRT for Prostate Cancer: Results of the Montpellier Cancer Center
por: Riou, Olivier, et al.
Publicado: (2012)

Feasibility study of adaptive radiotherapy with Ethos for breast cancer
por: Galand, Arthur, et al.
Publicado: (2023)

Robustness of Breast Margins with Volumetric Modulated Arc Therapy without a Six-Degrees-of-Freedom Couch: A Dosimetric Evaluation
por: Prunaretty, Jessica, et al.
Publicado: (2023)

Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray
por: Bibeau, Frédéric, et al.
Publicado: (2006)

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial
por: Assenat, Eric, et al.
Publicado: (2015)

Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ
por: Riou, Olivier, et al.
Publicado: (2012)

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
por: Azria, D, et al.
Publicado: (2003)

Surgical Management of Neuroendocrine Tumours of the Pancreas
por: Souche, Regis, et al.
Publicado: (2020)

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial
por: Bourgier, Céline, et al.
Publicado: (2018)

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial()
por: Azria, David, et al.
Publicado: (2015)

Twin machines validation for VMAT treatments using electronic portal-imaging device: a multicenter study
por: Fenoglietto, P., et al.
Publicado: (2016)

Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
por: Assenat, E., et al.
Publicado: (2021)

Clinical Significance and Prognostic Value of CA72-4 Compared with CEA and CA19-9 in Patients with Gastric Cancer
por: Ychou, M., et al.
Publicado: (2000)

Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study
por: Riou, Olivier, et al.
Publicado: (2014)

Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas
por: Llacer-Moscardo, Carmen, et al.
Publicado: (2010)

Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
por: Azria, David, et al.
Publicado: (2018)

Prolonged Survival after Recurrence in HCC Resected Patients Using Repeated Curative Therapies: Never Give Up!
por: Toubert, Cyprien, et al.
Publicado: (2022)

Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
por: Riou, Olivier, et al.
Publicado: (2023)

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
por: Lièvre, Astrid, et al.
Publicado: (2009)

A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
por: Deshayes, Emmanuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_769h81hff3a3ujr5bopppf5kbe